Table 2.
Associations between PhenoAge, PhenoAgeAccel, and all-cause mortality on follow-up.
| Variable | HR (95% CI) | ||
|---|---|---|---|
| Model 1a | Model 2b | Model 3c | |
| PhenoAge (per year) | 1.05 (1.02, 1.08)∗∗∗ | 1.06 (1.03, 1.09)∗∗∗ | 1.04 (1.01, 1.08)∗ |
| PhenoAge (per 10 years) | 1.63 (1.27, 2.11)∗∗∗ | 1.74 (1.34, 2.27)∗∗∗ | 1.51 (1.10, 2.08)∗ |
| PhenoAgeAccel subgroups | |||
| Negative | Reference | Reference | Reference |
| Positive | 2.29 (1.38, 3.81)∗∗ | 2.58 (1.51, 4.41)∗∗ | 2.08 (1.14, 3.80)∗ |
Results are based on COX regression analysis. HR: hazard ratio; PhenoAge: phenotypic age; PhenoAgeAccel: phenotypic age acceleration. aModel 1 adjusted for chronological age. bModel 2 additionally adjusted for lesion number, disease count, and revascularization. cModel 3 additionally adjusted for other traditional cardiovascular risk factors, including gender, smoking, drinking, body mass index, serum uric acid, creatine kinase, creatine phosphokinase isoenzyme, total cholesterol, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and N-terminal probrain natriuretic peptide. +P < 0.1; ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001.